BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 23316018)

  • 1. Hepatocellular carcinoma-associated mesenchymal stem cells promote hepatocarcinoma progression: role of the S100A4-miR155-SOCS1-MMP9 axis.
    Yan XL; Jia YL; Chen L; Zeng Q; Zhou JN; Fu CJ; Chen HX; Yuan HF; Li ZW; Shi L; Xu YC; Wang JX; Zhang XM; He LJ; Zhai C; Yue W; Pei XT
    Hepatology; 2013 Jun; 57(6):2274-86. PubMed ID: 23316018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
    Zhang J; Zhang DL; Jiao XL; Dong Q
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4.
    Dou C; Liu Z; Xu M; Jia Y; Wang Y; Li Q; Yang W; Zheng X; Tu K; Liu Q
    Cancer Lett; 2016 Oct; 381(2):380-90. PubMed ID: 27544906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis in vitro.
    Cui JF; Liu YK; Zhang LJ; Shen HL; Song HY; Dai Z; Yu YL; Zhang Y; Sun RX; Chen J; Tang ZY; Yang PY
    Proteomics; 2006 Nov; 6(22):5953-61. PubMed ID: 17051636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
    Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
    Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of S100A4 expression by HBx protein promotes proliferation of hepatocellular carcinoma cells and its correlation with clinical survival.
    Zhu K; Huang W; Wang W; Liao L; Li S; Yang S; Xu J; Li L; Meng M; Xie Y; He S; Tang W; Zhou H; Liang L; Gao H; Zhao Y; Hou Z; Tan J; Li R
    Gene; 2020 Jul; 749():144679. PubMed ID: 32330536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomal S100A4 derived from highly metastatic hepatocellular carcinoma cells promotes metastasis by activating STAT3.
    Sun H; Wang C; Hu B; Gao X; Zou T; Luo Q; Chen M; Fu Y; Sheng Y; Zhang K; Zheng Y; Ren X; Yan S; Geng Y; Yang L; Dong Q; Qin L
    Signal Transduct Target Ther; 2021 May; 6(1):187. PubMed ID: 34035222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of suppressors of cytokine signaling 3 promotes aggressiveness in hepatocellular carcinoma.
    Wu WY; Kim H; Zhang CL; Meng XL; Wu ZS
    J Invest Surg; 2014 Aug; 27(4):197-204. PubMed ID: 24476004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma.
    Gui Y; Yeganeh M; Donates YC; Tobelaim WS; Chababi W; Mayhue M; Yoshimura A; Ramanathan S; Saucier C; Ilangumaran S
    Oncogene; 2015 Nov; 34(46):5718-28. PubMed ID: 25728680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma.
    Tsai WC; Hsu PW; Lai TC; Chau GY; Lin CW; Chen CM; Lin CD; Liao YL; Wang JL; Chau YP; Hsu MT; Hsiao M; Huang HD; Tsou AP
    Hepatology; 2009 May; 49(5):1571-82. PubMed ID: 19296470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice.
    Zhang W; Sun HC; Wang WQ; Zhang QB; Zhuang PY; Xiong YQ; Zhu XD; Xu HX; Kong LQ; Wu WZ; Wang L; Song TQ; Li Q; Tang ZY
    Gastroenterology; 2012 Dec; 143(6):1641-1649.e5. PubMed ID: 22922424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological significance of S100A4 expression in human hepatocellular carcinoma.
    Liu Z; Liu H; Pan H; Du Q; Liang J
    J Int Med Res; 2013 Apr; 41(2):457-62. PubMed ID: 23781010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble factors from adipose tissue-derived mesenchymal stem cells promote canine hepatocellular carcinoma cell proliferation and invasion.
    Teshima T; Matsumoto H; Koyama H
    PLoS One; 2018; 13(1):e0191539. PubMed ID: 29346427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Mobility Group Box 1 Promotes Hepatocellular Carcinoma Progression through miR-21-Mediated Matrix Metalloproteinase Activity.
    Chen M; Liu Y; Varley P; Chang Y; He XX; Huang H; Tang D; Lotze MT; Lin J; Tsung A
    Cancer Res; 2015 Apr; 75(8):1645-56. PubMed ID: 25720799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice.
    Li Y; Chen L; Chan TH; Liu M; Kong KL; Qiu JL; Li Y; Yuan YF; Guan XY
    Gastroenterology; 2013 Jan; 144(1):179-191.e4. PubMed ID: 23022495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2.
    Wong CC; Wong CM; Tung EK; Au SL; Lee JM; Poon RT; Man K; Ng IO
    Gastroenterology; 2011 Jan; 140(1):322-31. PubMed ID: 20951699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
    Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
    J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.
    Zhou JN; Zeng Q; Wang HY; Zhang B; Li ST; Nan X; Cao N; Fu CJ; Yan XL; Jia YL; Wang JX; Zhao AH; Li ZW; Li YH; Xie XY; Zhang XM; Dong Y; Xu YC; He LJ; Yue W; Pei XT
    Hepatology; 2015 Sep; 62(3):801-15. PubMed ID: 25953743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells seldomly fuse with hepatocellular carcinoma cells and are mainly distributed in the tumor stroma in mouse models.
    Li GC; Ye QH; Dong QZ; Ren N; Jia HL; Qin LX
    Oncol Rep; 2013 Feb; 29(2):713-9. PubMed ID: 23232668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.